Comments from President Trump completely changed the market’s calculus about the next Federal Reserve Chair.

After inching higher at the open, all three indexes are flat or lower at midday.

Stocks have been quiet this week. The S&P is teasing new highs. All systems go.

After our November outlook highlighted upside potential in ZEC, price found support near $300 and is now consolidating in a bullish triangle on the daily chart, setting the stage for a possible wave 5 breakout toward 2018 highs.

State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring costs and a higher-than-expected expense outlook for 2026.

A major shift has taken place in the markets.

Despite the possibility for a near term spike in prices, the reality is that President Trump’s foreign policy is going to be a major factor that will keep oil prices from spiraling out of control.

Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies, and related products to a broad range of health care customers.

While long-term growth is limited, the current valuation implies a level of pessimism that understates the company’s resilience, pricing power, and shareholder-return capacity.

No rate changes are expected from the People's Bank of China, Bank of Japan, or Bank Indonesia.

Although the benchmark indices opened higher, they traded positively throughout the session and ultimately closed green.

The Dow managed to meet the target zone at 49500-600.

The EUR/USD outlook remains soft as the dollar surges after a surprise decline in jobless claims.

The US dollar is softer against all the G10 currencies, but the general consolidation seen this week continues.

The relatively weak performance of shares in the homebuilder industry for the past two calendar years is, on first glance, surprising.

Wall Street’s largest banks have closed out 2025 on a high note, delivering record revenues and rising profits as a rebound in dealmaking, buoyant trading activity, and resilient lending helped defy earlier fears of a slowdown.

Eli Lilly's stock experiences strong momentum prior to its upcoming earnings report, supported by robust analyst targets and a solid growth narrative, despite recent volatility.

The pace of technological change means millions of Americans face an uncertain labor market.

Confirming its status as one of the year's most volatile commodities, copper futures resumed their downward trajectory on Friday.

Consumer borrowing cratered further in November, likely reflecting growing consumer stress, as price inflation persists and credit cards become maxed out.